Drug delivery firm plans distribution center, 46 jobs
Simple Meds LLC, an Indianapolis-based startup, is seeking a city tax break that will help it open a local distribution facility and hire up to 46 people by the end of 2020.
Health Care & Insurance
Articles
Lilly’s Cyramza gets new marketing approval
Eli Lilly and Co.'s drug Cyramza has been approved as a treatment for lung cancer, regulators said. The Food and Drug Administration is allowing Lilly to market the drug as a treatment for cases that have spread.
Alzheimer’s tests present dilemma of knowing the future
While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.
Indy dentist accused of $260,000 in false claims
Marion County Prosecutor Terry Curry said Dr. Bernice Avant was charged Thursday with one count of Medicaid fraud and four counts of theft.
The moving target bedeviling attempts to cut health care costs
In health care, 5 percent of patients account for 50 percent of costs. Trouble is, those patients aren’t the same from year to year. Not even close.
Report: Nearly 43 million Americans have unpaid medical bills
The findings suggest that many Americans are being trapped by debt because they are confused by the notices they get from hospitals and insurance companies about the cost of treatment.
Covance shareholder sues over $6.1B LabCorp deal
A Covance Inc. investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc.’s conflict-tainted advice. Covance has major laboratory operations in Indianapolis.
Nearly $50M in state funds sought for medical campus
Officials from three state universities seek almost $50 million in state funding for a planned medical school campus they would share in downtown Evansville. That’s up from the original plan of $35 million.
Lilly rheumatoid arthritis drug meets goals in final-stage trial
If approved, Baricitinib may bring Lilly $673 million in 2020, according to the average of five analysts’ estimates compiled by Bloomberg.
Hoosier docs, hospitals cut jobs while peers nationally keep hiring
In spite of the divergent trend, Indiana still employs more workers in hospitals and doctors’ offices than the nation as a whole.
Health law adding to primary care doctor shortage
A survey found that 81 percent of doctors say they are over-extended or at full capacity, and 44 percent plan to cut back on the number of patients they see, retire, work part-time or close their practice to new patients.
IU’s proton therapy center closes after 2,079 patients
John Kerstiens, the center's chief operating officer and chief financial officer, said the staff's mood on the final day of the center's operation was fraught with emotion.
Regrets of ending an employer health plan
This spring, Keith Pitzele ended his company’s health plan and sent his workers to the Obamacare exchange. It was a bumpy experience he’s glad he won’t have to repeat next year. Does that mean most employers won’t follow suit?
Three hospitals part of plan to provide Ebola care
Indianapolis hospital leaders have spent the past two months ironing out a plan to deal with any cases of Ebola that emerge in Indiana. The plan is aimed at ensuring effective care while also minimizing the need to bring other hospital services to a virtual halt while patients are under care.
Feds drop case against former Lilly scientists accused of stealing secrets
Federal prosecutors dropped all charges against two scientists accused of stealing trade secrets worth $55 million from Eli Lilly and Co. after new information emerged last month, according to a court motion made Friday.
Growth rate for U.S. health tab may have hit bottom
U.S. health care spending grew by the slowest rate in more than a half-century last year, but a speed-up is expected as the economy finally gets traction.
Lilly competitor claims early success with Alzheimer’s drug
Biogen Idec Inc. shares rose Tuesday after the company said its Alzheimer’s drug showed promising early results and will be quickly moved into a final-stage trial.
WellPoint makes switch back to Anthem name
The nation's second-largest health insurance company has officially changed its corporate name from WellPoint Inc. to Anthem Inc. The Indianapolis-based insurer's stock starts trading Wednesday under the ticker symbol ANTM.
Lilly in $440M osteoporosis patch deal with Zosano
Eli Lilly and Co. said Tuesday it will team up with Zosano Pharma Corp. on an experimental osteoporosis patch in a deal that could be worth more than $440 million.
Indiana’s Monroe Hospital files Chapter 11 liquidation plan
About one month after receiving court approval to sell its 32-bed acute-care surgical hospital in Bloomington, Monroe Hospital LLC filed a Chapter 11 plan of liquidation.